Abiomed Aims To Boost Impella Automation With Opsens License
This article was originally published in The Gray Sheet
Executive Summary
Abiomed has inked an exclusive license to optical sensor technology that the firm suggests will be used to develop “smart” pumping algorithms for its Impella heart pump catheter.